Infection in cystic fibrosis.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D003550:Cystic Fibrosis / Q000150:complications / Q000382:microbiology*; D006190:Haemophilus / Q000302:isolation & purification; D006192:Haemophilus Infections / Q000150:complications; D006801:Humans; D008171:Lung Diseases / Q000382:microbiology; D011336:Probability; D011552:Pseudomonas Infections / Q000150:complications; D011550:Pseudomonas aeruginosa; D013203:Staphylococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents